Eurofins expands its GMP footprint in Spain

Luca Salvi, Eurofins BioPharma ProductTesting Spain, LucaSalvi@eurofins.com

In August 2014, Eurofins completed the acquisition of Sabater Pharma, a fully certified bio-pharma product testing laboratory, located in Barcelona, with an excellent reputation in the domestic market and recognised as one of the leading GMP laboratories in Spain.

This laboratory has now been merged with existing GMP operations in Barcelona and integrated into Eurofins BioPharma Product Testing global network. It counts with a surface of more than 1.700 sqm, approximately 40 FTE scientists and capabilities for fully comprehensive small molecule GMP service offerings, including: chemistry (raw materials & pharmaceutical release testing), ICH stability testing, microbiological non-sterile testing and sterility testing using isolator technology.

Fully harmonised, the laboratory adopted Eurofins BioPharma Product Testing's Quality Policy Manual, CAPA/Exceptions Management System and Document Management System. By operating under the same policies, procedures and guidelines, Barcelona's laboratory can now support the needs of multinational clients in Spain with a very high level of consistency with services provided by Eurofins in the US as well as other European countries.

This expanded GMP footprint in Barcelona allows Eurofins BioPharma Product Testing to deploy its flexible service models in Spain. In parallel with the traditional Fee for Service model, it will strongly boost Professional Scientific Services (PSS) for clients seeking greater flexibility in testing and staffing solutions. And, in particular, availability of space and full range of GMP testing techniques under the same roof makes this location especially suitable for our clients, Full Time Equivalent (FTE) programmes (dedicated full-time employees to work on client projects within our facilities).

For the most complete range of harmonised biopharmaceutical GMP product testing solutions, contact:GMP_EU@eurofins.com.